These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33527865)

  • 1. A novel technique to evaluate nail softening effects of different urea formulations.
    Nguyen HX; Kim Y; Kekatpure TD; Lesica E; Banga AK
    Pharm Dev Technol; 2021 Apr; 26(4):403-411. PubMed ID: 33527865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers.
    Khengar RH; Jones SA; Turner RB; Forbes B; Brown MB
    Pharm Res; 2007 Dec; 24(12):2207-12. PubMed ID: 17665289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Tampucci S; Mailland F
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ciclopirox nail lacquer with enhanced permeation and retention.
    Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
    Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into keratinolytic enzymes to enhance ungual drug delivery.
    Mohorcic M; Torkar A; Friedrich J; Kristl J; Murdan S
    Int J Pharm; 2007 Mar; 332(1-2):196-201. PubMed ID: 17097244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Naftifine Application for Transungual Delivery.
    Šveikauskaitė I; Briedis V
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32635240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
    Täuber A; Müller-Goymann CC
    Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.
    Fritsch H; Stettendorf S; Hegemann L
    Dermatology; 1992; 185(1):32-6. PubMed ID: 1386263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery.
    Nogueiras-Nieto L; Gómez-Amoza JL; Delgado-Charro MB; Otero-Espinar FJ
    J Control Release; 2011 Dec; 156(3):337-44. PubMed ID: 21906642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
    Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
    Vejnovic I; Huonder C; Betz G
    Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Ability of a Novel Miconazole Formulation To Penetrate Nail by Using Three
    Christensen L; Turner R; Weaver S; Caserta F; Long L; Ghannoum M; Brown M
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
    Bohn M; Kraemer KT
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of terbinafine hydrochloride and urea with an in situ film-forming system for nail targeting treatment.
    Yang F; Yu X; Shao W; Guo P; Cao S; Wang M; Wang Y; Wu C; Xu Y
    Int J Pharm; 2020 Jul; 585():119497. PubMed ID: 32504773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems.
    Naumann S; Meyer JP; Kiesow A; Mrestani Y; Wohlrab J; Neubert RH
    J Control Release; 2014 Apr; 180():60-70. PubMed ID: 24560884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration.
    Gómez EC; Anguiano Igea S; Gómez Amoza JL; Otero Espinar FJ
    Eur J Pharm Sci; 2018 May; 117():270-278. PubMed ID: 29501459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro.
    Lusiana ; Reichl S; Müller-Goymann CC
    Eur J Pharm Biopharm; 2013 Aug; 84(3):599-605. PubMed ID: 23419812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtilisin-γ-glutamyl transpeptidase: a novel combination as ungual enhancer for prospective topical application.
    Tiwary E; Gupta R
    J Pharm Sci; 2010 Dec; 99(12):4866-73. PubMed ID: 20572051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.